UK WINNERS & LOSERS SUMMARY: Future Surges As It Sees Results In Line Read More
UK Earnings, Trading Statements Calendar - Next 7 Days Read More
Faron Pharmaceuticals Gets Green Light For New Traumakine Trial Read More
Faron Pharmaceuticals "Encouraged" After Latest Matins Trial Findings Read More
Faron Pharmaceuticals Buys Rights For AOC3 Antagonist Platform Read More
Faron Pharmaceuticals Alters Traumakine Study After US FDA Feedback Read More
Faron Pharma To Test Clevegen In Patients With Ovarian Cancer Read More
Faron Pharma Gets Approval For Part II Trial Of Clevegen Drug Read More
Faron Pharma Files For Arbitration Amid Traumakine Deal Termination Read More
Faron Pharmaceuticals Pleased With Clevegen Clinical Trial Performance Read More
Faron Pharmaceuticals Inks Share Liquidity Pact With Lago Kapital Read More
Faron Pharmaceuticals Says US Regulator Approves Clevegen Drug Status Read More
Faron Pharmaceuticals Applies For Nasdaq First North Growth Listing Read More
UK WINNERS & LOSERS SUMMARY: Games Workshop And Beazley Top FTSE 250 Read More
Faron Pharmaceuticals Opens Private Placing To Fund Clevegen Progress Read More
LONDON MARKET CLOSE: Upbeat Global Data Promotes Strong End To Week Read More
Faron Pharmaceuticals Unable To Explain Significant Shares Price Surge Read More
Faron Pharmaceuticals To Test New Lower Dose In Clevegen Study Read More
Manufacturer Ends Traumakine Agreement With Faron Pharmaceuticals Read More
(Alliance News) - Faron Pharmaceuticals Oy on Monday said its loss narrowed considerably in the first half of 2019, after it cut back on research & development spending and opted to end a firm Read More
